JW Lifescience Corporation (KRX:234080)

JW Lifescience Revenue

JW Lifescience had revenue of 57.95B KRW in the quarter ending September 30, 2024, with 13.32% growth. This brings the company's revenue in the last twelve months to 221.32B, up 8.78% year-over-year. In the year 2023, JW Lifescience had annual revenue of 206.86B with 9.49% growth.

• Revenue (ttm): 221.32B
• Revenue Growth: +8.78%
• P/S Ratio: 0.74
• Revenue / Employee: 735.28M
• Employees: 301
• Market Cap: 164.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	206.86B	17.93B	9.49%
Dec 31, 2022	188.93B	19.11B	11.26%
Dec 31, 2021	169.82B	-13.70B	-7.47%
Dec 31, 2020	183.52B	13.30B	7.81%
Dec 31, 2019	170.22B	14.99B	9.66%